Final report on phase i trial of WR-2721 before protracted fractionated radiation therapy

Cysteine Protection against X Irradiation

Harvey M. Patt, E. B. Tyree, R. L. Straube et al. · Science · 1949 · 599 citations

Radiation Medicine, Radiation Exposure, X Irradiation +4

Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.

John M. Yuhas · PubMed · 1980 · 294 citations

Normal Tissues, Oncology, Biochemistry +14

Differential Chemoprotection of Normal and Malignant Tissues<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>

John M. Yuhas, John B. Storer · JNCI Journal of the National Cancer Institute · 1969 · 265 citations

Radiation Physics, Radiation Effect, Radiation Exposure +31

Radioprotection of tumor and normal tissues by thiophosphate compounds

Theodore L. Phillips, Lawrence J. Kane, Joella F. Utley · Cancer · 1973 · 136 citations · Full text

Emt-6 Mammary Carcinoma, Thiophosphate Compounds, Solid Emt-6 Carcinoma +14

Toxicity of WR-2721 administered in single and multiple doses

Morton M. Kligerman, Donna Glover, Andrew T. Turrisi et al. · International Journal of Radiation Oncology*Biology*Physics · 1984 · 127 citations

Multiple Doses, Medicine, Poisoning +7